| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |